http://ipkitten.blogspot.com/2025/08/never-too-late-if-you-missed-ipkat-last_21.html
Don’t miss a beat! Catch up on the latest IP news with the IPKat.Where legal expertise and felinegrace meet: the IPKat at work.PatentsRose Hughes reported on the EPO Boards of Appeal decision in T 0070/23, which held that an “immunogenic composition” product claim could not be interpreted as having therapeutic efficacy as a limitation, aligning with recent interpretations of the EPO Enlarged
Content reproduced from The IPKat as permitted under the Creative Commons Licence (UK).
